Lower self-reported ART adherence among adolescents in boarding schools compared to day schools
- PMID: 38346421
- PMCID: PMC11317543
- DOI: 10.1097/QAI.0000000000003400
Lower self-reported ART adherence among adolescents in boarding schools compared to day schools
Abstract
Introduction: Adolescents living with HIV (ALH) have poorer adherence to antiretroviral therapy (ART) than adults. Many ALH in sub-Saharan Africa (SSA) are enrolled in boarding schools where stigma is pervasive and may impact adherence.
Methods: We collected sociodemographic data, school information, medical history, and viral load (VL) data from ALH age 14-19 in 25 HIV clinics in 3 counties in Kenya. Using generalized estimating equations, we compared ART adherence in ALH attending day and boarding schools.
Results: Of 880 ALH, 798 (91%) were enrolled in school, of whom 189 (24%) were in boarding schools. Of those in school, median age was 16 (IQR: 15, 18), 55% were female, 78% had a parent as a primary caregiver, and 74% were on DTG-based ART. Median age at ART initiation was 6 years (IQR 3, 10).Overall, 227 (29%) ALH self-reported missing ART when school was in session (40% in boarding and 25% in day school). After adjusting for sociodemographic and HIV care characteristics, ALH in boarding schools were significantly more likely to self-report missing ART than those in day schools (adjusted Prevalence Ratio (aPR): 1.47, 95% CI 1.18, 1.83, p=0.001). Among 194 ALH, only 60% had undetectable (<20 copies/ml) HIV viral load (62% day schools and 51% boarding schools)(p=0.097).
Conclusion: ALH had high self-reported non-adherence overall, with worse adherence among those in boarding schools. Schools remain a critical untapped resource for improving ALH outcomes.
Copyright © 2024 Wolters Kluwer Health, Inc. All rights reserved.
Conflict of interest statement
Figures
Similar articles
-
Positive STEPS: Enhancing Medication Adherence and Achieving Viral Load Suppression in Youth Living With HIV in the United States-Results From an Efficacious Stepped Care, Randomized Controlled Trial.J Acquir Immune Defic Syndr. 2025 May 1;99(1):64-74. doi: 10.1097/QAI.0000000000003639. J Acquir Immune Defic Syndr. 2025. PMID: 39881440 Free PMC article. Clinical Trial.
-
Accuracy of measures for antiretroviral adherence in people living with HIV.Cochrane Database Syst Rev. 2022 Jul 25;7(7):CD013080. doi: 10.1002/14651858.CD013080.pub2. Cochrane Database Syst Rev. 2022. PMID: 35871531 Free PMC article.
-
Point-of-care viral load tests to detect high HIV viral load in people living with HIV/AIDS attending health facilities.Cochrane Database Syst Rev. 2022 Mar 10;3(3):CD013208. doi: 10.1002/14651858.CD013208.pub2. Cochrane Database Syst Rev. 2022. PMID: 35266555 Free PMC article.
-
Financial incentives for reduced alcohol use and increased isoniazid adherence during tuberculosis preventive therapy among people with HIV in Uganda: an open-label, factorial randomised controlled trial.Lancet Glob Health. 2023 Dec;11(12):e1899-e1910. doi: 10.1016/S2214-109X(23)00436-9. Lancet Glob Health. 2023. PMID: 37973340 Free PMC article. Clinical Trial.
-
Characterizing the HIV care continuum among children and adolescents with HIV in eastern and southern Africa in the era of "Universal Test and Treat": A systematic review and meta-analysis.J Int AIDS Soc. 2025 Jun;28(6):e26526. doi: 10.1002/jia2.26526. J Int AIDS Soc. 2025. PMID: 40515449 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous